LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $215,422 | -39.7% | 182,561 | -27.9% | 0.00% | -50.0% |
Q2 2023 | $357,118 | -1.2% | 253,275 | +5.1% | 0.00% | 0.0% |
Q1 2023 | $361,533 | +18.0% | 241,022 | -8.0% | 0.00% | 0.0% |
Q4 2022 | $306,425 | -6.0% | 261,902 | -9.2% | 0.00% | 0.0% |
Q3 2022 | $326,000 | +52.3% | 288,299 | +113.0% | 0.00% | +100.0% |
Q2 2022 | $214,000 | +1088.9% | 135,328 | +1027.7% | 0.00% | – |
Q1 2022 | $18,000 | +28.6% | 12,000 | -17.8% | 0.00% | – |
Q3 2020 | $14,000 | -71.4% | 14,601 | -74.2% | 0.00% | – |
Q2 2020 | $49,000 | +16.7% | 56,541 | +11.5% | 0.00% | – |
Q1 2020 | $42,000 | +110.0% | 50,718 | +129.0% | 0.00% | – |
Q4 2019 | $20,000 | – | 22,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
Ergoteles LLC | 490,895 | $555,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |